Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 28, 2021
ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 24, 2020
A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers.
Journal: Cancer cell
Published: August 23, 2018
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acquired Resistance to Osimertinib.
Journal: JAMA oncology
Published: August 04, 2018
Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2018
Raising the bar: the future of EGFR inhibition in non-small lung cancer.
Journal: Translational lung cancer research
Published: January 05, 2018
Correction: KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer.
Journal: eLife
Published: October 27, 2017
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 18, 2017
Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.
Journal: Nature communications
Published: June 10, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.
Journal: Cancer research
Published: December 14, 2016
Last Updated: 09/26/2026